Coronary Microvascular Resistance as a Predictor of the Placebo-Controlled Response to Percutaneous Coronary Intervention
JACC: Cardiovascular Interventions · 2026-05 · 19 (10) · 1259-1270
DOI: 10.1016/j.jcin.2026.01.305 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2026-05. Verfasst von Daniel J Taylor und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom; Insigneo Institute for I…. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Microcirculation, Coronary Circulation, Angina, Stable. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: NIHR Barts Biomedical Research Centre, Sheffield Hospitals Charity, Philips.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom; Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield, United Kingdom;…
- Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom; Department of Cardiology and Cardiothoracic Surgery, Sheffield Teaching Hospitals NHS Trust, S…
- Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom; Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield, United Kingdom.
- Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield, United Kingdom; School of Computer Science, University of Sheffield, Sheffield, United Kingdom.
- Imperial College London, London, United Kingdom; Imperial College Healthcare NHS Trust, London, United Kingdom.
Förderung
- NIHR Barts Biomedical Research Centre
- Sheffield Hospitals Charity
- Philips
- NIHR Imperial Biomedical Research Centre
- Wellcome Trust
Zitieren
APA
Taylor, D. J., Yones, E., Newman, T., Gosling, R., Halliday, I., Xu, X., Saxton, H., Czechowicz, K., Narracott, A., Biancardi, A. M., Hose, R., Shun-Shin, M. J., Gunn, J. P., Al-Lamee, R., & Morris, P. D. (2026). Coronary Microvascular Resistance as a Predictor of the Placebo-Controlled Response to Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions, 19(10), 1259-1270. https://doi.org/10.1016/j.jcin.2026.01.305
Vancouver
Taylor DJ, Yones E, Newman T, Gosling R, Halliday I, Xu X, et al. Coronary Microvascular Resistance as a Predictor of the Placebo-Controlled Response to Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions. 2026;19(10):1259-1270. doi:10.1016/j.jcin.2026.01.305
BibTeX
@article{Taylor2026,
author = {Taylor, Daniel J and Yones, Eron and Newman, Tom and Gosling, Rebecca and Halliday, Ian and Xu, Xu and Saxton, Harry and Czechowicz, Krzysztof and Narracott, Andrew and Biancardi, Alberto M and Hose, Rod and Shun-Shin, Matthew J and Gunn, Julian P and Al-Lamee, Rasha and Morris, Paul D},
title = {Coronary Microvascular Resistance as a Predictor of the Placebo-Controlled Response to Percutaneous Coronary Intervention},
journal = {JACC: Cardiovascular Interventions},
year = {2026},
volume = {19},
number = {10},
pages = {1259--1270},
doi = {10.1016/j.jcin.2026.01.305}
}
EUVIMED